MAPT and Alzheimer disease: In Alzheimer’s disease (AD) models, for instance, PANoptosis is often triggered by pathological protein aggregates like amyloid-beta (Aβ) or tau, which typically activate the NLRP3 inflammasome, a key component of the PANoptosome.